Analyzing the TCGA and the National Cancer Institute REpository for Molecular BRAin Neoplastic Data (NCI REMBRANDT) datasets, high TfR1 levels were found correlate with shorter overall survival in patients with glioma, and similar results were found when investigating protein expression data from grade II-IV TMAs [20]. The gene discussed is TFRC; the disease is glioma.